PT2306988E - Formulação farmacêutica para o tratamento do tracto digestivo superior - Google Patents

Formulação farmacêutica para o tratamento do tracto digestivo superior

Info

Publication number
PT2306988E
PT2306988E PT98000235T PT09800023T PT2306988E PT 2306988 E PT2306988 E PT 2306988E PT 98000235 T PT98000235 T PT 98000235T PT 09800023 T PT09800023 T PT 09800023T PT 2306988 E PT2306988 E PT 2306988E
Authority
PT
Portugal
Prior art keywords
treating
pharmaceutical formulation
digestive tract
upper digestive
antiinflammatory
Prior art date
Application number
PT98000235T
Other languages
English (en)
Inventor
Rudolf Wilhelm
Markus Proels
Original Assignee
Falk Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39951664&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2306988(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Falk Pharma Gmbh filed Critical Falk Pharma Gmbh
Publication of PT2306988E publication Critical patent/PT2306988E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
PT98000235T 2008-07-21 2009-07-02 Formulação farmacêutica para o tratamento do tracto digestivo superior PT2306988E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08013091A EP2151235B1 (de) 2008-07-21 2008-07-21 Pharmazeutische Formulierung zur Behandlung des oberen Verdauungstraktes

Publications (1)

Publication Number Publication Date
PT2306988E true PT2306988E (pt) 2013-02-15

Family

ID=39951664

Family Applications (2)

Application Number Title Priority Date Filing Date
PT08013091T PT2151235E (pt) 2008-07-21 2008-07-21 Formulação farmacêutica para o tratamento do trato digestivo superior
PT98000235T PT2306988E (pt) 2008-07-21 2009-07-02 Formulação farmacêutica para o tratamento do tracto digestivo superior

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT08013091T PT2151235E (pt) 2008-07-21 2008-07-21 Formulação farmacêutica para o tratamento do trato digestivo superior

Country Status (24)

Country Link
US (2) US8580300B2 (pt)
EP (2) EP2151235B1 (pt)
JP (2) JP5616889B2 (pt)
CN (1) CN102159196B (pt)
AT (1) ATE498396T1 (pt)
AU (1) AU2009273361B2 (pt)
CA (1) CA2731312C (pt)
CY (2) CY1111878T1 (pt)
DE (1) DE502008002621D1 (pt)
DK (2) DK2151235T3 (pt)
EA (1) EA018465B1 (pt)
ES (2) ES2358158T3 (pt)
HK (1) HK1149907A1 (pt)
HR (2) HRP20110208T1 (pt)
IL (1) IL210779A (pt)
ME (2) ME01256B (pt)
NZ (1) NZ590593A (pt)
PL (2) PL2151235T3 (pt)
PT (2) PT2151235E (pt)
RS (2) RS51649B (pt)
SI (2) SI2151235T1 (pt)
UA (1) UA100759C2 (pt)
WO (1) WO2010009961A1 (pt)
ZA (1) ZA201100283B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200200562T2 (tr) 1999-06-14 2002-05-21 Cosmo S.P.A Vücutta kontrollü şekilde salgılanabilen ve nahoş tadı önleyebilen ağızdan alınmaya mahsus farmasötik bileşimler
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
RS51649B (en) * 2008-07-21 2011-10-31 Dr. Falk Pharma Gmbh. PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF THE UPPER DIGESTIVE TRACT
US20110097401A1 (en) 2009-06-12 2011-04-28 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
DK3403654T3 (da) 2009-10-01 2019-08-26 Adare Dev I L P Oralt administrerede kortikosteroidsammensætninger
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
EP2886108B2 (de) * 2013-12-23 2022-11-02 Dr. Falk Pharma Gmbh Optimierte pharmazeutische Formulierung zur Behandlung von entzündlichen Veränderungen des Ösophagus
TWI777515B (zh) 2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4332394A1 (de) 1993-09-23 1995-03-30 Falk Pharma Gmbh Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
US5639475A (en) * 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules
US5607697A (en) * 1995-06-07 1997-03-04 Cima Labs, Incorporated Taste masking microparticles for oral dosage forms
US5807578A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
US5807577A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
GB9611364D0 (en) * 1996-05-31 1996-08-07 Smithkline Beecham Plc Composition
US6350470B1 (en) * 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
JP3818789B2 (ja) * 1999-02-18 2006-09-06 三菱化学フーズ株式会社 易崩壊性錠剤
JP4038772B2 (ja) 2001-07-11 2008-01-30 敏朗 関根 光合成微生物の培養方法と装置
CN1578657A (zh) * 2001-09-25 2005-02-09 兰贝克赛实验室有限公司 制备快速溶解剂型的方法
CA2467747A1 (en) * 2001-11-20 2003-05-30 Dmi Biosciences, Inc. Methods and products for oral care
US20030215502A1 (en) * 2002-03-20 2003-11-20 Elan Pharma International Limited Fast dissolving dosage forms having reduced friability
SE0401031D0 (sv) * 2004-04-22 2004-04-22 Duocort Ab A new glucocorticoid replacement therapy
US20060013873A1 (en) * 2004-07-16 2006-01-19 Chih-Chiang Yang Bioadhesive dosage form of steroids
US20070071817A1 (en) * 2005-09-26 2007-03-29 Phyzz, Inc. Effervescent oral care compositions and method of use
JP2009526860A (ja) * 2006-02-15 2009-07-23 ティカ レーケメデル アーベー 安定したコルチコステロイド混合物
EP2170348B1 (en) * 2007-06-22 2016-08-10 Dompé farmaceutici s.p.a. Effervescent tablets for inhalatory use
EP2205213A2 (en) * 2007-10-01 2010-07-14 Laboratorios Lesvi, S.L. Orodispersible tablets
RS51649B (en) * 2008-07-21 2011-10-31 Dr. Falk Pharma Gmbh. PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF THE UPPER DIGESTIVE TRACT
US20110097401A1 (en) * 2009-06-12 2011-04-28 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders

Also Published As

Publication number Publication date
HRP20130171T1 (hr) 2013-03-31
AU2009273361B2 (en) 2014-03-20
SI2151235T1 (sl) 2011-04-29
ES2399321T3 (es) 2013-03-27
CY1113719T1 (el) 2016-06-22
JP2011528679A (ja) 2011-11-24
DE502008002621D1 (de) 2011-03-31
ES2358158T3 (es) 2011-05-06
NZ590593A (en) 2012-07-27
PT2151235E (pt) 2011-03-21
HK1149907A1 (en) 2011-10-21
CN102159196B (zh) 2013-05-08
EP2151235B1 (de) 2011-02-16
UA100759C2 (uk) 2013-01-25
SI2306988T1 (sl) 2013-03-29
RS51649B (en) 2011-10-31
EP2151235A1 (de) 2010-02-10
EA018465B1 (ru) 2013-08-30
CA2731312C (en) 2016-05-10
CA2731312A1 (en) 2010-01-28
WO2010009961A1 (de) 2010-01-28
ATE498396T1 (de) 2011-03-15
DK2151235T3 (da) 2011-04-11
US20140079646A1 (en) 2014-03-20
ZA201100283B (en) 2011-10-26
ME01494B (me) 2014-04-20
CY1111878T1 (el) 2015-11-04
PL2306988T3 (pl) 2013-04-30
JP6209495B2 (ja) 2017-10-04
JP5616889B2 (ja) 2014-10-29
ME01256B (me) 2013-06-20
RS52662B (en) 2013-06-28
EA201100229A1 (ru) 2011-08-30
JP2014221827A (ja) 2014-11-27
EP2306988B1 (de) 2013-01-09
US20110123460A1 (en) 2011-05-26
PL2151235T3 (pl) 2011-05-31
IL210779A (en) 2015-07-30
HRP20110208T1 (hr) 2011-04-30
EP2306988A1 (de) 2011-04-13
US8580300B2 (en) 2013-11-12
IL210779A0 (en) 2011-03-31
DK2306988T3 (da) 2013-03-18
AU2009273361A1 (en) 2010-01-28
CN102159196A (zh) 2011-08-17

Similar Documents

Publication Publication Date Title
HK1149907A1 (en) Pharmaceutical formulation for treating the upper digestive tract
EP2440210A4 (en) METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
WO2010127099A3 (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
WO2009014650A3 (en) Recombinant vibrio cholerae exotoxins
WO2011112229A3 (en) Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
WO2008028193A3 (en) Colon-targeted oral formulations of cytidine analogs
WO2012027065A3 (en) Combination therapy for treatment of disease
WO2009111611A3 (en) Compounds, compositions and methods for the treatment of islet amyloid polypeptide (iapp) accumulation in diabetes
FR2953142B1 (fr) Appareil de delivrance regulee d'un gaz,notamment appareil d'assistance respiratoire
WO2009031606A1 (ja) 関節炎治療及び予防剤
MY159251A (en) Processes for the manufacture of a pharmaceutically active agent
WO2010081722A3 (en) Orally disintegrating tablets for the treatment of pain
WO2011113000A8 (en) Novel ester containing compositions and methods
WO2007115286A3 (en) Combinations of therapeutic agents for treating cancer
EP2023894A4 (en) FIXED COMBINATION DOSAGE FOR TREATING MIGRAINE
WO2012064130A3 (ko) 대장 선택성 셀레콕시브 전구체 화합물 및 이를 유효성분으로 함유하는 대장성 질환 치료 또는 예방용 약학조성물
WO2011002814A3 (en) Sulfonamido - biphenyloxyacetic acid compounds
PT2344166E (pt) Composição farmacêutica para o tratamento da irritação gastrointestinal
IL207977A0 (en) Therapy for disorders of the proximal digestive tract
WO2007138577A3 (en) Methods of generating a neural tissue using muscle-derived cells
UA96289C2 (ru) Способ получения лекарственного средства на основе ингибитора протеаз распылительной сушкой (варианты) и препарат (варианты)
UA38368U (ru) Лечебно-профилактический фитосироп "иммуностимулин"
WO2010124873A8 (en) 3- (2, 2, 2, trimethylhydrazinium) propionate dihydrate (meldonium) for treating parkinson' s disease
AU2014202051B2 (en) Progesterone for the treatment of preterm birth
WO2007100623A3 (en) Hydroxylamines and derivatives for the inhibition of complement activation